HighLife
Developer of a novel transcatheter replacement system designed to help in the treatment of mitral regurgitation. The company's system targets optimal treatment outcomes as it can be delivered through ...
Valuation
$0
Share Price
N/A
Total Raised
$71M
Last Round
N/A